In the first of a two-part series with TB and HIV experts at the Bill & Melinda Gates Foundation, Dr. Stefano Bertozzi, director of HIV and tuberculosis programs at the Foundation, gives his thoughts on what lies ahead this year in HIV and TB building on key developments from the past year and a half. In his role, Dr. Bertozzi oversees grants in HIV vaccine development, biomedical prevention research, diagnostics development and resistance monitoring, and strategies for introduction and scaling-up of interventions. He has held past leadership roles at UNAIDS, the World Health Organization, the World Bank, and the National Institute of Public Health (INSP) in Mexico.
The following is a guest post By Sharon Weir, Ph.D. of MEASURE Evaluation For almost 35 years, HIV/AIDS has been a household word across the globe. […]
The following is a guest post by Stephanie Mullen, DrPH, and Jim Thomas, PhD of MEASURE Evaluation USAID announced September 26 a new approach to fight […]
A trial to test the safety of, and immune response prompted by, the latest candidate for a vaccine to protect against Zika virus infection has begun […]
Citing overlooked social, economic, health impacts, study estimates West Africa Ebola outbreak costs at more than $53 billion
Estimate exceeds previous estimates by more than $20 billion Deaths from non-Ebola causes contributed to highest West Africa outbreak costs, authors say During the 2013 to […]